Ozone Application Before Fissure Sealants

May 13, 2025 updated by: IRCCS Burlo Garofolo

The Effect of Ozone Application Before Fissure Sealants: a Split Mouth Randomized Controlled Trial

Decay is a multifactorial infective degenerative disease of hard dental tissues, caused by Streptococcus mutans and Lactobacillus forming the bacterial biofilm of teeth surfaces. Decays generally evolve in fissures and pits of secondary molars. Pits and fissure sealants prevent decays if performed in two years from eruption. Ozone has bactericidal effect and remineralizing capacity on enamel.

The aim of this study is to assess the effectiveness of ozone application before sealants in increasing their duration in time.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

67

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 16 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • first or second secondary molars to be sealed
  • possibility to isolate with rubber dam both the teeth involved
  • no clear signs of pigmentations
  • good general health

Exclusion Criteria:

  • latex allergy
  • epilepsy or other severe neurological pathologies
  • psychiatric disease
  • excessive sensibility to electrical current
  • severe asthma
  • enamel disorders, such as amelogenesis imperfect, white spots, fluorosis or Molar Incisors Hypomineralization

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ozone therapy
Ozone application before pits and fissure sealants
One minute of pretreatment with ozone by using the OzoneDTA device
cleansing of the occlusal surfaces with a nylon brush and polishing toothpaste; surface etching with 36% orthophosphoric acid for 30'', surface cleaning and drying for 30 '', application of the sealing material, polymerization for 60'';
Active Comparator: Pits and fissure sealants
cleansing of the occlusal surfaces with a nylon brush and polishing toothpaste; surface etching with 36% orthophosphoric acid for 30'', surface cleaning and drying for 30 '', application of the sealing material, polymerization for 60'';

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sealants failure
Time Frame: 12 months after sealant
Frequency of sealed failure defined as presence of to one or more of these outcomes: Marginal fissure; Sealant fracture; Decay; Marginal pigmentations; Sealant detachment Evaluation of the relative frequency of the different causes of failure
12 months after sealant

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sealants failure
Time Frame: 6 months after sealant
Frequency of sealed failure defined as presence of to one or more of these outcomes: Marginal fissure; Sealant fracture; Decay; Marginal pigmentations; Sealant detachment Evaluation of the relative frequency of the different causes of failure
6 months after sealant
Sealants failure
Time Frame: 24 months after sealant
Frequency of sealed failure defined as presence of to one or more of these outcomes: Marginal fissure; Sealant fracture; Decay; Marginal pigmentations; Sealant detachment Evaluation of the relative frequency of the different causes of failure
24 months after sealant
Secondary decay in failed sealants
Time Frame: 6 months after sealant
Frequency of secondary decay in teeth with failed sealants
6 months after sealant
Secondary decay in failed sealants
Time Frame: 12 months after sealant
Frequency of secondary decay in teeth with failed sealants
12 months after sealant
Secondary decay in failed sealants
Time Frame: 24 months after sealant
Frequency of secondary decay in teeth with failed sealants
24 months after sealant

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Milena Cadenaro, DDS,MSc,PhD, IRCCS Burlo Garofolo
  • Principal Investigator: Maddalena Chermetz, DDS,MSc, IRCCS Burlo Garofolo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 17, 2019

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

July 30, 2019

First Submitted That Met QC Criteria

July 30, 2019

First Posted (Actual)

August 1, 2019

Study Record Updates

Last Update Posted (Actual)

May 16, 2025

Last Update Submitted That Met QC Criteria

May 13, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • RC 02/2019

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Data collected during the study will be available from the Study Director on reasonable request after evaluation of a protocol approved by an Ethical Committee

IPD Sharing Time Frame

After publication of data on peer reviewed journals

IPD Sharing Access Criteria

Data collected during the study will be available from the Study Director on reasonable request after evaluation of a protocol approved by an Ethical Committee

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caries,Dental

Clinical Trials on Ozone

Subscribe